
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
The U.K’s National Institute for Health and Care Excellence (NICE) on Wednesday recommended Pfizer Inc’s PFE Adcetris (brentuximab vedotin) for adult patients with advanced Hodgkin lymphoma. The recommendation covers brentuximab vedotin in combination with …